Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Information about the 2019 Novel Coronavirus
Atrial Fibrillation is Associated with Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR: Insights From the PARTNER 2A and PARTNER 2 S3i Trials Biviano, A., Nazif, T., Dizon, J., Garan, H., Crowley, A., Malaisrie, S., Makkar, R., Thourani, V., Mack, M., Szeto, W. Y., Fearon, W., Leon, M., Kodali, S. ELSEVIER SCIENCE INC. 2017: B46–B47
View details for Web of Science ID 000413459200107